Dr. Payal Kohli, a cardiologist with Cherry Creek Heart in Denver, and a DocWire News Section Advisor, talks about ...
Rivaroxaban plus aspirin reduced ischemic risk of the limb, brain, and heart in peripheral artery disease (PAD) after ...
The benefit of rivaroxaban monotherapy for patients with atrial fibrillation (AF) after coronary stenting was dependent ...
Four out of 10 people in a middle-age population in Sweden had coronary artery disease (CAD), with one in 20 having ...
Peripheral artery disease (PAD) was associated with continuous and linearly increasing risk for venous thromboembolism ...
Rivaroxaban reduced major cardiovascular (CV) events and limb events in patients with peripheral artery disease (PAD) ...
In patients with heart failure with reduced ejection fraction (HFrEF), omecamtiv mecarbil significantly reduced the risk ...
Advertisement
Advertisement
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.